pSivida Corp. Stock Nasdaq

Stocks

09/08/16	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/07/16	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/05/16	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/09/15	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/09/15	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
ARGENX SE	-1.39%	-6.15%	+56.05%	+71.53%	54.49B
WUXI APPTEC CO., LTD.	+3.13%	+11.16%	+67.30%	+94.35%	55.93B
INSMED INCORPORATED	-0.29%	-5.66%	+6.87%	+431.11%	23.87B
BIONTECH SE	+0.52%	-2.94%	-17.96%	-15.33%	22.86B
WUXI BIOLOGICS (CAYMAN) INC.	+3.51%	+7.50%	+47.81%	-3.33%	20B
GENMAB A/S	+1.94%	+0.21%	+39.31%	-29.41%	17.48B
PHARMAESSENTIA CORPORATION	+10.00%	-2.06%	+210.10%	+370.99%	15.39B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+7.69%	+4.38%	+56.51%	+712.88%	15.19B
EXELIXIS, INC.	-0.22%	-0.62%	+26.55%	+190.57%	14.02B
Average	+2.41%	+0.34%	+54.73%	+202.60%	26.58B
Weighted average by Cap.	+2.00%	+0.47%	+53.00%	+157.78%